• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

LI-RADS 形态学类型预测肝癌患者根治性切除术后的预后。

LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection.

机构信息

Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

Department of Radiology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.

出版信息

Ann Surg Oncol. 2023 Aug;30(8):4876-4885. doi: 10.1245/s10434-023-13494-4. Epub 2023 May 3.

DOI:10.1245/s10434-023-13494-4
PMID:37133569
Abstract

PURPOSE

This study aimed to explore the association of preoperative magnetic resonance imaging (MRI) tumor morphological classification with early recurrence (ER) and overall survival (OS) after radical surgery of hepatocellular carcinoma (HCC).

PATIENTS AND METHODS

A retrospective analysis of 296 patients with HCC who underwent radical resection was performed. On the basis of LI-RADS, tumor imaging morphology was classified into three types. The clinical imaging features, ER, and survival rates of three types were compared. Univariate and multivariate Cox regression analyses were conducted to identify prognostic factors associated with OS and ER after hepatectomy for HCC.

RESULTS

There were 167 tumors of type 1, 95 of type 2, and 34 of type 3. In patients with type 3 HCC, postoperative mortality and ER were significantly higher than in patients with type 1 and type 2 (55.9% versus 32.6% versus 27.5% and 52.9% versus 33.7% versus 28.7%). In multivariate analysis, the LI-RADS morphological type was a stronger risk factor for predicting poor OS [hazard ratio (HR) 2.77, 95% confidence interval (CI) 1.59-4.85, P < 0.001] and ER (HR 2.14, 95% CI 1.24-3.70, P = 0.007). A subgroup analysis revealed that type 3 was associated with poor OS and ER in > 5 cm cases but not in < 5 cm cases.

CONCLUSIONS

ER and OS of patients with HCC undergoing radical surgery can be predicted using the preoperative tumor LI-RADS morphological type, which could help to select personalized treatment plans for patients with HCC in the future.

摘要

目的

本研究旨在探讨术前磁共振成像(MRI)肿瘤形态学分类与肝癌(HCC)根治性手术后早期复发(ER)和总生存(OS)的关系。

方法

回顾性分析 296 例接受根治性切除术的 HCC 患者。基于 LI-RADS,将肿瘤影像学形态分为 3 型。比较三种类型的临床影像学特征、ER 和生存率。采用单因素和多因素 Cox 回归分析确定与 HCC 肝切除术后 OS 和 ER 相关的预后因素。

结果

1 型肿瘤 167 个,2 型肿瘤 95 个,3 型肿瘤 34 个。3 型 HCC 患者术后死亡率和 ER 明显高于 1 型和 2 型(55.9%比 32.6%比 27.5%和 52.9%比 33.7%比 28.7%)。多因素分析显示,LI-RADS 形态类型是预测不良 OS 的更强危险因素[风险比(HR)2.77,95%置信区间(CI)1.59-4.85,P<0.001]和 ER(HR 2.14,95%CI 1.24-3.70,P=0.007)。亚组分析显示,3 型与>5 cm 病例的不良 OS 和 ER 相关,但与<5 cm 病例无关。

结论

术前肿瘤 LI-RADS 形态类型可预测 HCC 根治性手术患者的 ER 和 OS,有助于为 HCC 患者选择个体化治疗方案。

相似文献

1
LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection.LI-RADS 形态学类型预测肝癌患者根治性切除术后的预后。
Ann Surg Oncol. 2023 Aug;30(8):4876-4885. doi: 10.1245/s10434-023-13494-4. Epub 2023 May 3.
2
Prognosis after Curative Resection of Single Hepatocellular Carcinoma with A Focus on LI-RADS Targetoid Appearance on Preoperative Gadoxetic Acid-Enhanced MRI.根治性切除单个肝细胞癌的预后:术前钆塞酸增强 MRI 的 LI-RADS 靶样外观的重点。
Korean J Radiol. 2021 Nov;22(11):1786-1796. doi: 10.3348/kjr.2020.1428. Epub 2021 Jul 26.
3
LI-RADS category 5 hepatocellular carcinoma: preoperative gadoxetic acid-enhanced MRI for early recurrence risk stratification after curative resection.LI-RADS 类别 5 肝细胞癌:根治性切除术后早期复发风险分层的术前钆塞酸增强 MRI。
Eur Radiol. 2021 Apr;31(4):2289-2302. doi: 10.1007/s00330-020-07303-9. Epub 2020 Oct 1.
4
Preoperative Nomogram Incorporating Clinical Factors, Serological Markers and LI-RADS MRI Features to Predict Early Recurrence of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization.术前列线图纳入临床因素、血清标志物和 LI-RADS MRI 特征预测经肝动脉化疗栓塞治疗的肝细胞癌早期复发。
Acad Radiol. 2023 Jul;30(7):1288-1297. doi: 10.1016/j.acra.2022.10.020. Epub 2022 Nov 21.
5
Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.肝脏影像报告和数据系统第 5 类:用于预测肝癌切除术后微血管侵犯和复发的 MRI 预测因子。
AJR Am J Roentgenol. 2019 Oct;213(4):821-830. doi: 10.2214/AJR.19.21168. Epub 2019 May 23.
6
Combined Hepatocellular-Cholangiocarcinoma: Magnetic Resonance Imaging Features and Prognosis According to Risk Factors for Hepatocellular Carcinoma.混合型肝细胞癌:基于肝细胞癌危险因素的磁共振成像特征和预后。
J Magn Reson Imaging. 2021 Jun;53(6):1803-1812. doi: 10.1002/jmri.27528. Epub 2021 Feb 9.
7
Gadoxetate-enhanced MRI Features of Proliferative Hepatocellular Carcinoma Are Prognostic after Surgery.钆塞酸增强 MRI 特征对手术后增殖型肝细胞癌具有预后价值。
Radiology. 2021 Sep;300(3):572-582. doi: 10.1148/radiol.2021204352. Epub 2021 Jul 6.
8
Texture Analysis Based on Preoperative Magnetic Resonance Imaging (MRI) and Conventional MRI Features for Predicting the Early Recurrence of Single Hepatocellular Carcinoma after Hepatectomy.基于术前磁共振成像(MRI)和常规 MRI 特征的纹理分析预测肝细胞癌术后早期复发
Acad Radiol. 2019 Sep;26(9):1164-1173. doi: 10.1016/j.acra.2018.10.011. Epub 2018 Nov 10.
9
Development and validation of the OSASH score to predict overall survival of hepatocellular carcinoma after surgical resection: a dual-institutional study.开发和验证 OSASH 评分以预测肝癌手术后的总生存:一项双机构研究。
Eur Radiol. 2023 Nov;33(11):7631-7645. doi: 10.1007/s00330-023-09725-7. Epub 2023 May 16.
10
LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium-enhanced magnetic resonance imaging.基于钆塞酸二钠增强磁共振成像的2018版肝脏影像报告和数据系统(LI-RADS)用于直径小于1.0厘米的肝细胞癌。
Eur Radiol. 2023 Aug;33(8):5792-5800. doi: 10.1007/s00330-023-09554-8. Epub 2023 Apr 5.

引用本文的文献

1
Clinical-Radiological Characteristic for Predicting Ultra-Early Recurrence After Liver Resection in Solitary Hepatocellular Carcinoma Patients.预测孤立性肝细胞癌患者肝切除术后超早期复发的临床-放射学特征
J Hepatocell Carcinoma. 2023 Dec 21;10:2323-2335. doi: 10.2147/JHC.S434955. eCollection 2023.
2
Reply to the Letter from Qian Ren and Yanjun Wang About the Article, "LI-RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection".对钱仁(音译)和王彦军(音译)就《LI-RADS形态学类型预测肝细胞癌根治性切除术后患者的预后》一文所写信件的回复
Ann Surg Oncol. 2024 Mar;31(3):1849-1850. doi: 10.1245/s10434-023-14557-2. Epub 2023 Nov 13.
3

本文引用的文献

1
The management of post-transplantation recurrence of hepatocellular carcinoma.移植后肝细胞癌复发的管理。
Clin Mol Hepatol. 2022 Jan;28(1):1-16. doi: 10.3350/cmh.2021.0217. Epub 2021 Oct 5.
2
Characteristics and Early Recurrence of Hepatocellular Carcinomas Categorized as LR-M: Comparison with Those Categorized as LR-4 or 5.LR-M 型肝癌的特征和早期复发:与 LR-4 或 5 型肝癌的比较。
J Magn Reson Imaging. 2021 Nov;54(5):1446-1454. doi: 10.1002/jmri.27650. Epub 2021 Apr 23.
3
Single Large Nodule (>5 cm) Prognosis in Hepatocellular Carcinoma: Kinship with Barcelona Clinic Liver Cancer (BCLC) Stage A or B?
Establishment and Validation of the LI-RADS Morphologic Type II Hepatocellular Carcinoma Early Recurrence Risk Scoring System.
LI-RADS 形态学类型 II 肝细胞癌早期复发风险评分系统的建立与验证。
J Gastrointest Surg. 2023 Dec;27(12):2787-2796. doi: 10.1007/s11605-023-05873-9. Epub 2023 Nov 6.
4
Letter to the Editor: Comment on: "LI‑RADS Morphological Type Predicts Prognosis of Patients with Hepatocellular Carcinoma After Radical Resection".致编辑的信:对“LI-RADS形态学类型预测肝细胞癌根治性切除术后患者的预后”的评论
Ann Surg Oncol. 2023 Dec;30(13):8023-8024. doi: 10.1245/s10434-023-14444-w. Epub 2023 Oct 12.
肝细胞癌中单个大结节(>5厘米)的预后:与巴塞罗那临床肝癌(BCLC)A期或B期的关系?
Med Sci Monit. 2020 Oct 16;26:e926797. doi: 10.12659/MSM.926797.
4
Can LI-RADS imaging features at gadoxetic acid-enhanced MRI predict aggressive features on pathology of single hepatocellular carcinoma?钆塞酸二钠增强MRI的LI-RADS成像特征能否预测单发性肝细胞癌病理上的侵袭性特征?
Eur J Radiol. 2020 Nov;132:109312. doi: 10.1016/j.ejrad.2020.109312. Epub 2020 Sep 28.
5
Anatomic versus non-anatomic resection for hepatocellular carcinoma, do we have an answer? A meta-analysis.解剖性与非解剖性肝切除术治疗肝细胞癌,我们有答案吗?一项荟萃分析。
Int J Surg. 2020 Aug;80:243-255. doi: 10.1016/j.ijsu.2020.05.008. Epub 2020 May 13.
6
Prognostic value of precise hepatic pedicle dissection in anatomical resection for patients with hepatocellular carcinoma.精确肝蒂解剖在肝细胞癌患者解剖性切除中的预后价值。
Medicine (Baltimore). 2020 Mar;99(10):e19475. doi: 10.1097/MD.0000000000019475.
7
Gross type of hepatocellular carcinoma reflects the tumor hypoxia, fibrosis, and stemness-related marker expression.肝细胞癌的大体类型反映了肿瘤的缺氧、纤维化和干性相关标志物的表达。
Hepatol Int. 2020 Mar;14(2):239-248. doi: 10.1007/s12072-020-10012-6. Epub 2020 Jan 29.
8
The Role of Preoperative Dynamic Contrast-enhanced 3.0-T MR Imaging in Predicting Early Recurrence in Patients With Early-Stage Hepatocellular Carcinomas After Curative Resection.术前动态对比增强3.0-T磁共振成像在预测早期肝细胞癌患者根治性切除术后早期复发中的作用
Front Oncol. 2019 Nov 28;9:1336. doi: 10.3389/fonc.2019.01336. eCollection 2019.
9
Interaction between the tumor microenvironment and resection margin in different gross types of hepatocellular carcinoma.肿瘤微环境与不同大体类型肝癌切缘之间的相互作用。
J Gastroenterol Hepatol. 2020 Apr;35(4):648-653. doi: 10.1111/jgh.14848. Epub 2019 Oct 27.
10
Prognosis After Resection of Barcelona Clinic Liver Cancer (BCLC) Stage 0, A, and B Hepatocellular Carcinoma: A Comprehensive Assessment of the Current BCLC Classification.巴塞罗那临床肝癌(BCLC)分期 0、A 和 B 期肝细胞癌切除后的预后:对当前 BCLC 分类的综合评估。
Ann Surg Oncol. 2019 Oct;26(11):3693-3700. doi: 10.1245/s10434-019-07580-9. Epub 2019 Jul 2.